News

Claritas Rx announcing availability of AI powered Performance Benchmarking

Claritas Rx In-depth Head-to-Head Comparison of KPIs Allows Market Access Teams to Make Smarter, Data-Driven Decisions

Understanding Competitor Fill Rates, Time-to-Fill, and Physician Experience Strengthens Strategies, Improves Patient Access and Fuels Brand Growth October 6, 2025 – SOUTH SAN FRANCISCO, CA – Claritas Rx, the patient journey experts, announced the availability of AI-powered Performance Benchmarking. The service turns comprehensive specialty data into a real-time view of how brands compare against their competitors. […]

Claritas Rx In-depth Head-to-Head Comparison of KPIs Allows Market Access Teams to Make Smarter, Data-Driven Decisions Read More »

BioXconomy quote from Claritas Rx CEO Mike Fitzgibbons

Mike Fitzgibbons Interviewed by BioXconomy on Access Analytics Product Launch

In a rapidly evolving healthcare landscape, life sciences organizations face mounting challenges in market access—particularly when it comes to rare and specialty diseases. Fragmented data sources, delays in reporting, and lack of actionable insights often create barriers for patients in need of timely therapy. In a recent interview with BioXconomy, Claritas Rx CEO Mike Fitzgibbons shares how Access Analytics is

Mike Fitzgibbons Interviewed by BioXconomy on Access Analytics Product Launch Read More »

Access Analytics news release

Claritas Rx Access Analytics Delivers Real-Time Visibility Into Biopharma Brand Performance

Real-Time Channel Intelligence Empowers Smarter Market Access and Better Patient Outcomes New Thought Leadership Entitled “One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains” Now Available September 8, 2025 – SOUTH SAN FRANCISCO, CA – Claritas Rx, the patient journey experts, announced the availability of Access Analytics that delivers real-time channel and competitive

Claritas Rx Access Analytics Delivers Real-Time Visibility Into Biopharma Brand Performance Read More »

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies

South San Francisco, CA, August 12, 2025 – Claritas Rx, the leader in intelligent solutions that provide real-time visibility across the entire patient journey, announced today it has been named to the prestigious Inc. 5000 list, the most respected ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most

Claritas Rx Named to the 2025 Inc. 5000 List, Ranking Among America’s Fastest-Growing Private Companies Read More »

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment

New White Paper Entitled “From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas” Now Available South San Francisco, CA, July 28, 2025 – Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announces the availability of its new white paper entitled “From Prescription to Abandonment:

Claritas Rx Offers Four Strategies to Mitigate Specialty Treatment Abandonment Read More »

Claritas Rx Patient Watchtower press release

Claritas Rx Launches First and Only Care Coordination Platform for Specialty and Rare Disease Patients

SaaS-based Patient Watchtower Uses AIML to Microtarget Patients Based on Risk Factors to Ensure They Receive Prompt Treatment Webinar Entitled “Achieve Specialty Pharma Success with AI: Enhance Care, Elevate Fill Rates by 20% and Improve Patient Adherence” Planned for May 15 APRIL 28, 2025 – LAS VEGAS, NV, ASEMBIA AXS25 – Claritas Rx, the leader

Claritas Rx Launches First and Only Care Coordination Platform for Specialty and Rare Disease Patients Read More »